Logomix ヒト幹細胞など様々な生物種の細胞機能を効率よく設計・改変する細胞エンジニアリング企業
6 known investors
Genome engineering-based drug discovery and biomanufacturing R&D support.
Investors · 6
Competitors · 5
by search overlapPhenomix Sciences12 shared keywords
Genomind8 shared keywordsGenomind provides pharmacogenetic testing and precision medicine software to help healthcare providers tailor medication prescriptions based on patients' genetic profiles, lifestyle, and environment. The platform integrates genetic data with clinical expertise to reduce adverse drug events and improve treatment outcomes across individual and population health settings.
NeoGenomics6 shared keywordsNeoGenomics provides oncology diagnostics and laboratory testing, offering over 500 tests across modalities including molecular testing, IHC, flow cytometry, FISH, next-generation sequencing, and comprehensive genomic profiling for solid tumors and hematologic cancers. It serves oncologists, patients, and biopharma partners in the US, supporting clinical care as well as drug development and clinical trials.
Metallomix5 shared keywordsMetallomix is a drug development company working on isotope-selective modulators using non-radioactive stable isotopes (currently zinc-64) to target inflammation and oxidative stress. It develops treatments for oncological, metabolic, neurological, and autoimmune conditions through its ISM (isotope-selective modulation) platform, with ongoing and planned clinical trials.</parameter>
<parameter name="founders">[{"full_name": "Max Temnik", "title": "Founder"}]
Meiogenix4 shared keywordsMeiogenix develops crop improvement technologies using targeted recombination to unlock genetic diversity in plants, helping breeders create elite crop varieties. Its tools serve plant breeders and the agricultural industry with a focus on productivity, sustainability, and disease resistance.
Companies competing with Logomix ヒト幹細胞など様々な生物種の細胞機能を効率よく設計・改変する細胞エンジニアリング企業 for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Logomix ヒト幹細胞など様々な生物種の細胞機能を効率よく設計・改変する細胞エンジニアリング企業 do?
- Genome engineering-based drug discovery and biomanufacturing R&D support.
- Who are Logomix ヒト幹細胞など様々な生物種の細胞機能を効率よく設計・改変する細胞エンジニアリング企業's investors?
- Logomix ヒト幹細胞など様々な生物種の細胞機能を効率よく設計・改変する細胞エンジニアリング企業's investors include Angel Bridge Co.,Ltd., Aozora Corporate Investment, Delight Ventures, Globis Capital Partners, MIRAI SOUZOU, UTokyo Innovation Platform Co. Ltd..